Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 378,203	$ 525,540
Short-term marketable debt securities	823,395	314,438
Accounts receivable, net	137,849	110,253
Inventory, net	85,876	71,083
Prepaid expenses and other current assets, net	40,723	33,800
Total current assets	1,466,046	1,055,114
Restricted cash	111,214	104,215
Property and equipment, net	145,915	136,813
Right-of-use assets, net	158,849	142,265
Intangible assets, net	25,921	6,760
Goodwill	77,257	3,290
Other assets, net	28,457	37,152
Total Assets	2,013,659	1,485,609
Current liabilities:
Accounts payable	54,442	38,551
Accrued compensation	119,646	83,219
Accrued expenses	77,889	68,345
Deferred revenue	50,753	35,468
Total current liabilities	302,730	225,583
Convertible senior notes, net	1,504,000	1,142,547
Long-term operating lease liabilities	178,463	164,292
Other long-term liabilities	127,773	92,834
Total Liabilities	2,112,966	1,625,256
Commitments and contingencies
Stockholders’ deficit:
Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of December 31, 2025 and 2024	0	0
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of December 31, 2025 and 2024; 130,635,301 and 123,994,006 shares issued and outstanding as of December 31, 2025 and 2024, respectively	1	1
Additional paid-in capital	2,900,056	2,443,788
Accumulated other comprehensive loss	(4,852)	(5,201)
Accumulated deficit	(2,994,512)	(2,578,235)
Total Stockholders’ Deficit	(99,307)	(139,647)
Total Liabilities and Stockholders’ Deficit	$ 2,013,659	$ 1,485,609